QA: Bioadaptives INC in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001575142_2024_Bioadaptives_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001575142, Bioadaptives INC

  xvar xval
0 AssetsCurrent 88,557
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 15,441
4 LiabilitiesCurrent 1,750,629
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 17,746
8 SellingGeneralAndAdministrativeExpense 101,478
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 138,262
11 remainder_Revenues 28,565
12 remainder_NetIncome -483,545
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 103,998
1 Liabilities 1,750,629
2 Expenses 257,486
3 Revenues 28,565
4 StockholdersEquity -1,646,631
5 NetIncome -712,466
6 ComprehensiveNetIncome -712,466
7 BaseVar 1,312,112
8 EconomicCapitalRatiobeforeLimitedLiability -4.64
9 EconomicCapitalRatio 0.252

Edgar->Model Mapping

Feature Distribution